Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Exploiting antifungal immunity in the clinical context217
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity177
Editorial Board88
Differential immune responses behind different celiac disease manifestations75
Three’s company: The cooperative signals behind the differentiation of Th9 cells69
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells67
Cellular stress and macrophage activation66
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity65
Editorial Board62
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi59
Aging of lymphoid stromal architecture impacts immune responses56
Resolving inflammatory links between myocardial infarction and vascular dementia54
Pyroptosis modulation by bacterial effector proteins52
Local and Cell-intrinsic complement: The new player in cancer progression51
Microbial metabolites and immunotherapy: Basic rationale and clinical indications51
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges50
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?48
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity47
Immunity to pathogenic fungi in the eye44
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)43
The noncanonical inflammasome-induced pyroptosis and septic shock42
Pyroptosis: A road to next-generation cancer immunotherapy41
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease41
Pyroptosis and the cellular consequences of gasdermin pores38
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity35
Interplay between the complement system and other immune pathways in the tumor microenvironment34
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment34
Immunity to fungi: Editorial overview32
Western diet influences on microbiome and carcinogenesis32
Neuroimmune interactions between itch neurons and skin microbes30
Specialized pro-resolving mediators as modulators of immune responses30
Cellular and molecular diversity in spondyloarthritis30
Autoimmune diabetes and targets for immunomodulation29
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets29
Interleukin-1β and cancer immune response27
The paradox of aging: Aging-related shifts in T cell function and metabolism27
The evolving biology of cross-presentation27
TREM2: A new player in the tumor microenvironment26
Adaptive NK cell response to human cytomegalovirus: Facts and open issues26
Antigen discovery for the development of cancer immunotherapy25
Recent developments in C3-targeted complement therapeutics24
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases24
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy23
Thymus aging and immune reconstitution, progresses and challenges23
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic22
T cell control of SARS-CoV-2: When, which, and where?22
Introduction to the Special Issue: Nutrition, microbiota and immunity22
Sialic acid and Siglec receptors in tumor immunity and immunotherapy22
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases22
T cell fate decisions during memory cell generation with aging21
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs21
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination21
Targeting the tissue-complosome for curbing inflammatory disease21
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity20
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy19
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy19
The glycoimmune landscape in health and disease19
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?19
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells19
Editorial Board19
The complement system in clinical oncology: Applications, limitations and challenges18
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice18
Cellular and molecular heterogeneity in systemic lupus erythematosus18
Publisher's note: Welcome Prof. Guido Kroemer18
Better safe than sorry: Naive T-cell dynamics in healthy ageing18
Natural killer cell responses to human oncogenic γ-herpesvirus infections18
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis18
Harnessing complement biomarkers for precision cancer care17
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease17
Emerging opportunities for C3 inhibition in the eye17
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review17
Proteostasis in T cell aging17
Human thymus in health and disease: Recent advances in diagnosis and biology16
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging16
Global aspects of celiac disease and food allergy16
The gut-enthesis axis and the pathogenesis of Spondyloarthritis15
The multisensory regulation of unconventional T cell homeostasis15
Corrigendum to “Nanoalum adjuvanted vaccines: Small details make a big difference” [Semin. Immunol. 56 (2021) 101544]15
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions15
Epigenetic and transcriptional control of gasdermins15
Identification of T cell antigens in the 21st century, as difficult as ever15
A major mechanism for immunomodulation: Dietary fibres and acid metabolites15
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics14
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond14
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation14
Durability of immune responses to SARS-CoV-2 infection and vaccination14
Siglecs as modulators of macrophage phenotype and function14
Unconventional protein secretion by gasdermin pores14
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches14
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases13
Microbial gasdermins: More than a billion years of pyroptotic-like cell death13
Systems analysis of innate and adaptive immunity in Long COVID12
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data12
Pyroptosis-induced inflammation and tissue damage12
Integrating immunopeptidome analysis for the design and development of cancer vaccines12
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC12
The role of ILC subsets in cancer12
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond11
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies11
Editorial Board11
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation11
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences11
Reparative inflammation in multiple sclerosis11
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas11
The gut-brain vascular axis in neuroinflammation11
Complement regulation in tumor immune evasion11
Regulatory T cells in allergic inflammation11
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease11
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions11
Galectins and Host–Pathogen Interactions: The roles in viral infections11
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function11
Systems analysis of human innate immunity in COVID-1910
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies10
To die or not to die: Gasdermins in intestinal health and disease10
The role of sialoglycans in modulating dendritic cell function and tumour immunity10
Publisher’s Note: A change in leadership10
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives10
Immunity to fungi in the lung10
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virus9
The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients9
The origins, manifestations, and potential treatments of allergic disorders9
Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions9
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging9
Editorial Board9
Editorial Board9
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging9
Complement component C3: A structural perspective and potential therapeutic implications9
1.0442140102386